Description
A photosensitizer used during photodynamic therapy to eliminate abnormal blood vessels in the eye that are associated with conditions such as macular degeneration; also inhibits autophagosome formation by directly targeting and modifying p62, a scaffold and adaptor protein that binds both polyubiquitinated proteins destined for degradation and LC3 on autophagosomal membranes
Formal name: (4R,4aS)-rel-18-ethenyl-4,4a-dihydro-3,4-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-24H,26H-benzo[b]porphine-9,13-dipropanoic acid, monomethyl ester
Synonyms: BPD-MA|CL 318,952
Molecular weight: 718.8
CAS: 129497-78-5
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy||Research Area|Neuroscience|Ophthalmology